VIPR2 and pancreatic insulinoma: As PAC1, VPAC1 and VPAC2 mRNAs were detected in a rat insulinoma cell line with PAC1 binding prevailing over that of VPAC1 and VPAC223, the PAC1 receptor seemed to be a promising alternative for targeting insulinomas.